A modified tapeworm medication could be a promising new treatment for endometriosis, an early study in mice hints.
In endometriosis, tissue similar to the lining of the uterus grows outside the organ, and these patches of tissue, called "lesions," trigger painful inflammation and heavy menstrual bleeding. In the new study, scientists fitted an anti-worm drug with nanotech armor, and it directly targeted these painful lesions in laboratory mice.
The treatment reduced inflammation and slowed or prevented further spread of the lesions, researchers reported in August in the journal Advanced Healthcare Materials. The team is already working on bringing the new drug to clinical trials and hopes this will bring fresh attention to an understudied disease with limited treatment options.
Rogue immune cells are a promising drug target
Endometriosis is a chronic, hormone-driven condition that affects roughly Read Entire Article
English (US)